It’s needless to say that the coronavirus has affected or altered every industry in one way or another. Healthcare marketing has been no exception. Many healthcare marketers are decreasing their promotional budget for this year in response to the virus and opting to increase their digital abilities. 

 

Since the virus has forced most countries to establish lockdown procedures marketing professionals have been forced to revisit traditional approaches to business. Heightened restrictions on access and business travel have changed marketing strategies, significantly. As in-person meetings have plunged there has been wide adoption of telemedicine. Furthermore, marketing and pharmaceutical companies are becoming more adaptive to regain control of the supply chains. 

 

We will continue to see things such as media inventory, active pharmaceutical ingredients, and information become more dynamic as people work hard to solve the large problems that the coronavirus has created. 

 

During the pandemic, there have been a number of drug launches and every company has taken its own divergent approach. The factors that every company must take into consideration include things such as treatment interruptions and clinical trial delays. Other issues involve the details of maneuvering around problems with prescription refills and supply chain disruptions. 

 

Moving forward the makers of medical devices and biopharma companies will have to adjust to the fallout from coronavirus. It’s important to ensure that companies are maintaining the flow of their critical medical communication. Even after the threat from the virus is completely under control and businesses are back up and running, marketing will operate differently than it did in the past.

 

Many large marketing and pharma companies will invest more in the development and flexibility of their departments and it will be more important to form agile plans that will help organizations to respond faster. 

 

Finally, there will be a renewed focus on patient communication as healthcare telemedicine has increased exponentially due to coronavirus. It will be interesting to watch how the technology is further developed as many providers will continue to leverage remote engagement alternatives.